Head and neck cancer trials in China

In China 216 Also abroad 944

216 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Tai Chi for Cancer-Related Fatigue During Radiotherapy in Patients With Head and Neck Cancer
Where
Chengdu
Age
18 years to 80 years
People
116
Run by
West China Hospital
See details and how to joinNCT07809776
Phase 2Not yet taking people in China
Nimotuzumab Plus Radiotherapy in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Beijing
Age
65 years and over
People
46
Run by
Ke Hu
See details and how to joinNCT07821242
Phase 2Taking people
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Where
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
Age
18 years to 64 years
People
257 worldwide
Run by
AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00
Phase 2Taking people
A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Chengdu
Age
18 years to 70 years
People
90
Run by
West China Hospital
See details and how to joinNCT07381075
Phase 2Not yet taking people in China
Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
Where
Shanghai
Age
18 years to 75 years
People
220
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07812467
Phase 2Taking people
Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma
Where
Guangzhou
Age
18 years to 70 years
People
40
Run by
Xuekui Liu
See details and how to joinNCT07814287
No phaseTaking people
Screening of Biomarkers and Related Mechanisms for RIX
Where
Hangzhou, Nanjing
Age
18 years to 75 years
People
50
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07170358
Phase 1Taking people
Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
Where
Chengdu
Age
18 years to 75 years
People
40
Run by
West China Hospital
See details and how to joinNCT07635277
Phase 2Taking people
A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants
Where
Chengdu, Shanghai
Age
18 years to 75 years
People
120
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07668154
Phase 2Taking people
To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies
Where
Xiamen
Age
18 years to 75 years
People
35
Run by
Neuboron Bio-SciTech Co., Ltd.
See details and how to joinNCT07795034
Phase 3Taking people
A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN
Where
Shanghai
Age
18 years to 75 years
People
180
Run by
Lepu Biopharma Co., Ltd.
See details and how to joinNCT05751512
Early phase 1Taking people
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Where
Wuxi
Age
18 years to 75 years
People
10
Run by
FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07459283
No phaseTaking people
A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
Where
Nanjing
Age
18 years to 100 years
People
3,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07532538
Phase 1Taking people
Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors
Where
Chengdu
Age
18 years to 65 years
People
9
Run by
West China Hospital
See details and how to joinNCT07625423
No phaseTaking people
Online Sharing for Head & Neck Cancer Support
Where
Chengdu
Age
18 years to 75 years
People
120
Run by
West China Hospital
See details and how to joinNCT07766226
Phase 2Taking people
Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Guangdong
Age
18 years to 75 years
People
22
Run by
Rui You
See details and how to joinNCT07371234
No phaseTaking people
Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma
Where
Guangzhou
Age
18 years to 80 years
People
750
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06755567
No phaseTaking people
Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer
Where
Kunming
Age
18 years to 75 years
People
40
Run by
Yunnan Cancer Hospital
See details and how to joinNCT07794813
Phase 1Taking people
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
Where
Changsha, Chongqing, Guangzhou, Shanghai, Taiyuan, Wuhan
Age
18 years to 75 years
People
570
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05194982
Phase 2Not yet taking people in China
A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
30
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07788950
Phase 2Not yet taking people in China
Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer
Where
Changsha, Shanghai
Age
18 years to 75 years
People
85
Run by
Fudan University
See details and how to joinNCT07780877
Phase 2Taking people
Sintilimab Plus Hypofractionated Radiotherapy Followed by Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Where
Hangzhou
Age
18 years to 75 years
People
27
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07781072
Phase 1Taking people
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Where
Jinan
Age
18 years to 75 years
People
299 worldwide
Run by
Huahui Health
See details and how to joinNCT07623369
Phase 2Not yet taking people in China
A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination With Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma
Where
Shanghai
Age
18 years to 75 years
People
20
Run by
Shanghai East Hospital
See details and how to joinNCT07778368
Phase 2Not yet taking people in China
Induction PD-1 Inhibitor and Chemotherapy Followed by Chemoradiotherapy in Unresectable or Inoperable HPV-negative LA-HNSCC
Where
Shanghai
Age
18 years to 75 years
People
104
Run by
Fudan University
See details and how to joinNCT07776340